Journal: Diagnostics

Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level

doi: 10.3390/diagnostics13243686

Figure Lengend Snippet: Advantages and disadvantages of FastBio-RBD TM (fluorescence immunoassay) and GenScript-cPASS TM (SVNT).

Article Snippet: The subjects were tested for the anti-SARS-CoV2-S-RBD antibody using FastBio-RBD TM and the GenScript-cPASS TM SVNT.

Techniques: Fluorescence, Clinical Proteomics, Inhibition, Binding Assay, Neutralization, Comparison, Enzyme-linked Immunosorbent Assay

Journal: Diagnostics

Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level

doi: 10.3390/diagnostics13243686

Figure Lengend Snippet: Advantages and disadvantages of FastBio-RBD TM (fluorescence immunoassay) and GenScript-cPASS TM (SVNT).

Article Snippet: GenScript-cPASS TM (SVNT) , - Scalable alternative in comparison to conventional neutralization assays - More sensitive in detecting neutralizing antibodies (nAbs) - Acceptable standard for various clinical and research settings , - Needs to be conducted in well-equipped immunology laboratories - ELISA readings require a skilled laboratory technician.

Techniques: Fluorescence, Clinical Proteomics, Inhibition, Binding Assay, Neutralization, Comparison, Enzyme-linked Immunosorbent Assay

Journal: Diagnostics

Article Title: The Protection Level of S-RBD SARS-CoV-2 Immunoglobulin G Antibodies Using the Chemiluminescent Immunoassay Compared to the Surrogate Virus Neutralization Test Method

doi: 10.3390/diagnostics14161776

Figure Lengend Snippet: Characteristics of the subjects.

Article Snippet: Blood plasma samples were examined to determine S-RBD SARS-CoV-2 IgG levels using Siemens ADVIA Centaur ® CLIA (Munich, Germany) and GenScript cPASS TM SVNT (Piscataway, NJ, USA).

Techniques: Infection

Journal: Diagnostics

Article Title: The Protection Level of S-RBD SARS-CoV-2 Immunoglobulin G Antibodies Using the Chemiluminescent Immunoassay Compared to the Surrogate Virus Neutralization Test Method

doi: 10.3390/diagnostics14161776

Figure Lengend Snippet: Correlation between the anti S-RBD antibody level using the CLIA and SVNT methods.

Article Snippet: Blood plasma samples were examined to determine S-RBD SARS-CoV-2 IgG levels using Siemens ADVIA Centaur ® CLIA (Munich, Germany) and GenScript cPASS TM SVNT (Piscataway, NJ, USA).

Techniques:

Journal: Diagnostics

Article Title: The Protection Level of S-RBD SARS-CoV-2 Immunoglobulin G Antibodies Using the Chemiluminescent Immunoassay Compared to the Surrogate Virus Neutralization Test Method

doi: 10.3390/diagnostics14161776

Figure Lengend Snippet: The diagnostic accuracy of S-RBD SARS-CoV-2 IgG CLIA cut-off point for the 30% inhibition level of SVNT.

Article Snippet: Blood plasma samples were examined to determine S-RBD SARS-CoV-2 IgG levels using Siemens ADVIA Centaur ® CLIA (Munich, Germany) and GenScript cPASS TM SVNT (Piscataway, NJ, USA).

Techniques: Diagnostic Assay, Inhibition

Journal: Diagnostics

Article Title: The Protection Level of S-RBD SARS-CoV-2 Immunoglobulin G Antibodies Using the Chemiluminescent Immunoassay Compared to the Surrogate Virus Neutralization Test Method

doi: 10.3390/diagnostics14161776

Figure Lengend Snippet: Receiver operating characteristic curve for S-RBD SARS-CoV-2 IgG CLIA. Area under the curve: 0.970. An ROC curve lying on the diagonal line reflects the performance of a diagnostic test (Blue Line) and the chance level (Red Line).

Article Snippet: Blood plasma samples were examined to determine S-RBD SARS-CoV-2 IgG levels using Siemens ADVIA Centaur ® CLIA (Munich, Germany) and GenScript cPASS TM SVNT (Piscataway, NJ, USA).

Techniques: Diagnostic Assay